About Lymphoma | Advocacy | Art | CAM | Clinical trials | Doctors - Experts - Centers | Guidelines at Diagnosis | News
Risk Factors | Side Effects | Statistics | Support | Symptoms | Tests | Treatments | Types of Lymphoma

Search Site         Guidelines at Diagnosis | About Clinical Trials            How to Help!

Patients Against Lymphoma

 

Treatment >  Radioimmunotherapy for
Other Subtypes and indications

Last update: 08/09/2010

TOPICS:

MCL and Aggressive Lymphoma | CLL / SLL | T-cell and Hodgkins | High-Risk / Transformed
Follicular - new types and indications
TOPIC SEARCH ~ Web

Here we link to study protocols investigating the safety and efficacy of RIT for indications beyond what RIT is already approved for.  

Each protocol will provide contact and location information.

Completed studies are included as these might be considered as Off-Protocol therapies.

 

 


MCL and Aggressive Lymphoma:

bullet
Phase 1 Study of Radio-sensitization Using Bortezomib (Velcade) for Relapsed Mantle Cell or Aggressive Lymphoma Patients in Radioimmunotherapy http://bit.ly/cfOftA
bullet
Zevalin-BEAM/BEAC With Autologous Stem Cell Support as Consolidation in First Line Treatment of Mantle Cell Lymphoma http://bit.ly/bbba12
bullet
Targeted Intensification Utilizing ZBEAM Followed by Autologous Stem Cell Transplantation (ASCT) in Patients With High-grade B-Cell Lymphoma (ZBEAM2)
bullet
Study of 90Y-DOTA-hLL2 as a Consolidation Therapy After R-CHOP in Patients With Diffuse Large B-Cell Lymphoma http://bit.ly/bxEC8Z
bullet
Zevalin Twice in Aggressive Non-Hodgkin Lymphoma http://bit.ly/daY0cI

CLL / SLL:

bullet
Study Looking at Effectiveness of 131-Tositumomab (Bexxar) Consolidation for Patients With CLL or SLL http://bit.ly/cJQCV7

T-cell and Hodgkins lymphoma:

bullet
Iodine I 131 Monoclonal Antibody BC8 (anti-cd45) and Autologous Stem Cell Transplant in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Treatment http://bit.ly/c2LbFW

(Hodgkin lymphoma - Must have CD45+ cells adjacent to the Reed Sternberg cells)
bullet
131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphoma http://bit.ly/9TQAW9

High risk b-cell lymphoma / transformed lymphoma:

bullet
High Dose Chemotherapy With Monoclonal Antibody and Radioimmunotherapy for High-Risk B-Cell NHL http://bit.ly/bO0uuF
bullet
Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant http://bit.ly/awVp5H
bullet
Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-refractory Low-grade or Transformed Low-grade B-cell Lymphoma (completed)

"The results from Phase 1/2 (RIT-I-000) and Phase 2 (RIT-II-001) studies of Tositumomab and Iodine I 131 Tositumomab (TST/I-131 TST) demonstrated that TST/ I-131 TST produced a high response rate in patients with chemotherapy-relapsed/refractory, low-grade or transformed low-grade Non-Hodgkin's Lymphoma (NHL). On the basis of these results this study was designed to compare the efficacy of TST/ I-131 TST to the last qualifying chemotherapy regimen in patients with chemotherapy-refractory, low-grade or transformed low-grade NHL."
bullet
CpG 7909 (immune adjuvant), Rituximab, and Zevalin in Treating Patients With NHL That is Recurrent or Did Not Respond to Previous Treatment http://bit.ly/9efFdm
bullet
Safety and Efficacy of 90Y Zevalin in Nonmyeloablative (mini) Transplantation for Lymphoid Malignancies http://bit.ly/diXeWj

Orbital b-cell lymphoma:

bullet
Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma (completed)

Follicular -new type of RIT:

bullet
Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma http://bit.ly/c80PPu
bullet
Bexxar or Zevalin in Treating Patients With Non-Hodgkin's Lymphoma http://bit.ly/asKpWL
(Not a new indication, but a test to compare efficacy and safety ... what a novel idea : )
bullet
Rituximab, Combination Chemotherapy, and Zevalin in Treating Patients With Stage I or Stage II Lymphoma (completed)
bullet
WM - Waldenstrom's Macroglobulinemia
bullet
Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia (completed)

Other

bullet
Donor Peripheral Blood Stem Cell Transplant and Pretargeted Radioimmunotherapy in Treating Patients With High-Risk Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome http://bit.ly/cDGLxa 

 

Resources

  1. Clinical Trials Search PAL
 
Disclaimer:  The information on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright 2004,  All Rights Reserved.